Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study

AIPW: An R Package for Augmented Inverse Probability Weighted Estimation of Average Causal Effects

(2021) Yongqi Zhong et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Augmented Inverse Probability Weighting and the Double Robustness Property

(2021) Christoph F. Kurz   MEDICAL DECISION MAKING

The Use of External Controls in FDA Regulatory Decision Making

(2021) Mahta Jahanshahi et al.   Therapeutic Innovation & Regulatory Science

Propensity scores using missingness pattern information: a practical guide

(2020) Helen A. Blake et al.   STATISTICS IN MEDICINE

A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data

(2020) Christen M. Gray et al.   DRUG SAFETY

A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)

(2020) Mercedeh Ghadessi et al.   Orphanet Journal of Rare Diseases

G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study

(2020) Arthur Chatton et al.   Scientific Reports

Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration

(2020) Talal Hilal et al.   JAMA Internal Medicine

Single-arm Trials With External Comparators and Confounder Misclassification

(2020) Michael Webster-Clark et al.   MEDICAL CARE

Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis

(2019) Tomas Mlcoch et al.   VALUE IN HEALTH

Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances

(2019) M Sanni Ali et al.   Frontiers in Pharmacology

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

(2018) Cesar A. Santa-Maria et al.   BREAST CANCER RESEARCH AND TREATMENT

OUP accepted manuscript

(2018)   AMERICAN JOURNAL OF EPIDEMIOLOGY

Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview

(2017) Nerys Woolacott et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The “Hispanic mortality paradox” revisited: Meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants' mortality

(2017) Eran Shor et al.   SOCIAL SCIENCE & MEDICINE

Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies

(2016) Megan S. Schuler et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

An Introduction to G Methods

(2016) Ashley I Naimi et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014

(2016) Anthony J Hatswell et al.   BMJ Open

Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration

(2016) Ariadna Tibau et al.   JAMA Oncology

The Propensity Score

(2015) Jason S. Haukoos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Introduction to propensity scores

(2014) Elizabeth J. Williamson et al.   RESPIROLOGY

Variance reduction in randomised trials by inverse probability weighting using the propensity score

(2013) Elizabeth J. Williamson et al.   STATISTICS IN MEDICINE

Doubly Robust Estimation of Causal Effects

(2011) Michele Jonsson Funk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Hazards of Hazard Ratios

(2009) Miguel A. Hernán   EPIDEMIOLOGY